Literature DB >> 17315853

Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes.

Dubravko Jelić1, Boris Mildner, Sanja Kostrun, Krunoslav Nujić, Donatella Verbanac, Ognjen Culić, Roberto Antolović, Wolfgang Brandt.   

Abstract

Tyrosine phosphorylation represents a unique signaling process that controls metabolic pathways, cell activation, growth and differentiation, membrane transport, apoptosis, neural, and other functions. We present here the three-dimensional structure of Fyn tyrosine kinase, a Src-family enzyme involved in T-cell receptor signal transduction. The structure of Fyn was modeled for homology using the Sybyl-Composer suite of programs for modeling. Procheck and Prosa II programs showed the high quality of the obtained three-dimensional model. Rosmarinic acid, a secondary metabolite of herbal plants, was discovered as a new Fyn kinase inhibitor using immunochemical and in silico methods. Two possible binding modes of rosmarinic acid were evaluated here, i.e., near to or in the ATP-binding site of kinase domain of Fyn. Enzyme kinetic experiments revealed that Fyn is inhibited by a linear-mixed noncompetitive mechanism of inhibition by rosmarinic acid. This indicates that rosmarinic acid binds to the second "non-ATP" binding site of the Fyn tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17315853     DOI: 10.1021/jm0607202

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression.

Authors:  Nam Joo Kang; Ki Won Lee; Bong Jik Shin; Sung Keun Jung; Mun Kyung Hwang; Ann M Bode; Yong-Seok Heo; Hyong Joo Lee; Zigang Dong
Journal:  Carcinogenesis       Date:  2008-12-10       Impact factor: 4.944

2.  SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts.

Authors:  Chengguo Wei; Khadija Banu; Felipe Garzon; John M Basgen; Nimrod Philippe; Zhengzi Yi; Ruijie Liu; Jui Choudhuri; Miguel Fribourg; Tong Liu; Arun Cumpelik; Jenny Wong; Mubeen Khan; Bhaskar Das; Karen Keung; Fadi Salem; Kirk N Campbell; Lewis Kaufman; Paolo Cravedi; Weijia Zhang; Philip J O'Connell; John Cijiang He; Barbara Murphy; Madhav C Menon
Journal:  J Am Soc Nephrol       Date:  2018-10-19       Impact factor: 10.121

3.  Tebrophen--an old polyphenol drug with anticancer potential.

Authors:  Ivica Rubelj; Višnja Stepanić; Dubravko Jelić; Nikolina Škrobot Vidaček; Andrea Ćukušić Kalajžić; Milena Ivanković; Krunoslav Nujić; Mario Matijašić; Donatella Verbanac
Journal:  Molecules       Date:  2012-06-28       Impact factor: 4.411

4.  Rapid Characterization of Chemical Components in Edible Mushroom Sparassis crispa by UPLC-Orbitrap MS Analysis and Potential Inhibitory Effects on Allergic Rhinitis.

Authors:  Zhixin Wang; Jingyu Liu; Xiangjian Zhong; Jinjie Li; Xin Wang; Linlin Ji; Xiaoya Shang
Journal:  Molecules       Date:  2019-08-20       Impact factor: 4.411

5.  Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells.

Authors:  Yunsheng Liu; Xiangping Xu; Han Tang; Yuchen Pan; Bing Hu; Guodong Huang
Journal:  Int J Mol Med       Date:  2021-03-02       Impact factor: 4.101

Review 6.  Biomedical features and therapeutic potential of rosmarinic acid.

Authors:  Saba Noor; Taj Mohammad; Malik Abdul Rub; Ali Raza; Naved Azum; Dharmendra Kumar Yadav; Md Imtaiyaz Hassan; Abdullah M Asiri
Journal:  Arch Pharm Res       Date:  2022-04-07       Impact factor: 6.010

7.  Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses.

Authors:  Andrea Comba; Patrick J Dunn; Anna E Argento; Padma Kadiyala; Maria Ventosa; Priti Patel; Daniel B Zamler; Felipe J Núñez; Lili Zhao; Maria G Castro; Pedro R Lowenstein
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

8.  Homology modeling a fast tool for drug discovery: current perspectives.

Authors:  V K Vyas; R D Ukawala; M Ghate; C Chintha
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

Review 9.  Fyn kinase inhibition as a novel therapy for Alzheimer's disease.

Authors:  Haakon B Nygaard; Christopher H van Dyck; Stephen M Strittmatter
Journal:  Alzheimers Res Ther       Date:  2014-02-05       Impact factor: 6.982

Review 10.  Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury.

Authors:  Md Jamal Uddin; Debra Dorotea; Eun Seon Pak; Hunjoo Ha
Journal:  Biomol Ther (Seoul)       Date:  2020-05-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.